Explore by goal
Compare clinician-guided weight-loss programs, including semaglutide and tirzepatide pathways, with route, pricing, eligibility and follow-up explained clearly.
What to consider
Compare clinician-guided weight-loss programs, including semaglutide and tirzepatide pathways, with route, pricing, eligibility and follow-up explained clearly.
10 programs
CIRx value. Clear choices.
Explore CIRx treatments first, followed by name-brand options with the same core active ingredient. Compare formats, care terms, and medicine costs to find the value that fits your care.
Products, doses, routes, and approved uses differ. Compounded treatments are not FDA-approved or approved generics of brand medicines. Insurance and manufacturer offers can change which option costs less.
Your weight goals deserve a plan built around you. Semaglutide targets appetite and fullness signals; this injection also contains vitamin B12. A clinician reviews your goals, the formula and individual suitability.
Medication, shipping, clinician review and ongoing support included.
Explore program
Looking for a more individual weight-care conversation? Semaglutide targets appetite signals; this pathway explores a clinician-selected lower-dose injection with vitamin B12. A clinician reviews your goals, the formula and individual suitability.
Medication, shipping, clinician review and ongoing support included.
Explore program
SemaMelt is an Epiq compounded sublingual tablet. Compare one-month plans and clinician-approved three-month maintenance at a fixed strength. Start, restart and dose changes require provider confirmation.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Wegovy® is a semaglutide injection used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Wegovy® is a semaglutide tablet used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore program
Your weight goals deserve a plan built around you. Tirzepatide targets appetite and fullness signals; this injection also contains vitamin B12. A clinician reviews your goals, the formula and individual suitability.
Medication, shipping, clinician review and ongoing support included.
Explore program
Looking for a more individual weight-care conversation? Tirzepatide targets appetite signals; this pathway explores a clinician-selected lower-dose injection with vitamin B12. A clinician reviews your goals, the formula and individual suitability.
Medication, shipping, clinician review and ongoing support included.
Explore program
TirzeMelt is an Epiq compounded sublingual tablet. Compare one-month plans and clinician-approved three-month maintenance at a fixed strength. Start, restart and dose changes require provider confirmation.
Medication, shipping, clinician review and ongoing support included.
Explore program
Make your weight goals part of a clear care plan. Zepbound® is a tirzepatide injection used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore programA different active ingredient. There is no matching CIRx formulation in the current catalog.
Make your weight goals part of a clear care plan. Foundayo™ is an orforglipron tablet used to reduce excess weight and help maintain weight loss in eligible patients. A clinician reviews your health history, eligibility and treatment options.
Medication, shipping, clinician review and ongoing support included.
Explore programConsider This
FAQ
Both are incretin-based medications, but they act on different receptor pathways. A clinician considers medical history, goals, tolerability, access and the exact product before recommending one.
No. Eligibility depends on a licensed clinician review and may vary by state, health history, current medications and pharmacy availability.
It describes a dosing philosophy, not a guaranteed side-effect profile or result. The prescriber determines whether a lower starting or maintenance approach is clinically appropriate.
No. Compounded drugs are not FDA approved. Their use must fit applicable law and an individual prescription, and they should not be represented as equivalent to an FDA-approved product.
Authoritative starting points
Private clinician review
Program pages are educational. Eligibility, treatment, route and availability are determined only after an independent clinical evaluation.
